The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

The EO states that while American citizens represent only 5% of the global population, they fund around 75% of global ...

Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The White House is trying to reassure the public that pharmaceutical innovation and drug company profits won't be harmed ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...